Artificial intelligence is accelerating drug discovery and diagnostics with notable breakthroughs. Researchers at MIT developed a generative AI model producing novel antibiotic structures from minimal chemical inputs, aiming to address antibiotic resistance. Meanwhile, AI systems have detected prostate cancer cases overlooked by pathologists, leveraging subtle tissue morphology changes. These advances exemplify AI’s transformative impact across pharmaceutical innovation and medical diagnostics.